Fluticasone Propionate and Salmeterol HFA

Prasco Laboratories🇺🇸 United States

FDA Page

Effective Date: Aug 1, 2022
Approval ID: 666c5b12-a4f7-4c53-8261-4742b5e5a6df
Products: 3 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use Fluticasone Propionate and Salmeterol HFA safely and effectively. See full prescribing information for Fluticasone Propionate and Salmeterol HFA. Fluticasone Propionate and Salmeterol HFA inhalation aerosol, for oral inhalation useInitial U.S. Approval: 2000

Quick Stats

Total Products3

Labelers2

Label Sections38

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.